Ariad Pharmaceuticals (ARIA) Reports Q1 EPS In-Line
More News related to ARIA
- ARIAD to Present Data on Pan-BCR-ABL Inhibitor AP24534 at 51st American Society of Hematology Meeting
- ARIAD to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
- Morning Movers 11/09: EWBC, CVM, REV, CGEN, RSH Higher; CHDX, SRZ, GTN, RPRX, VSR Lower
- JP Morgan Upgrades Ariad Pharmaceuticals (ARIA) to Overweight
- ARIAD Pharma (ARIA) Posts Q3 Loss of 21c, Misses Views by 3c
Ariad Pharmaceuticals (Nasdaq: ARIA) reports Q1 EPS of ($0.26) versus the analyst estimate of ($0.26). Revenue for the quarter was $1.9 million, versus the consensus of $2.78 million.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Related Categories
EarningsStocks Mentioned
+0.00Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
